EIGA Doc. 219/19
This publication provides the EIGA position and guidance on the manufacturing, bulk product storage, and cargo transport unit (cryogenic tankers and containers) filling validation activities that take place at a typical air separation unit (ASU) that is manufacturing medical oxygen, medical nitrogen, or both. Variations from the typical ASU process configurations can exist. Companies shall assess variations and determine if deviations from this guidance are necessary.
The approach and activities in this publication are designed to ensure that these gases, which are classified as drug products, have the claimed identity, strength, quality, and purity.
This publication addresses validation for ASU cryogenic manufacturing and cargo transport unit filling processes relating to medical oxygen and medical nitrogen meeting the requirements of the European monographs.
The publication is part of the programme to develop Globally Harmonised publications amongst Regional Gas Associations.
...
Fonte: EIGA
ID 19212 | ECHA 15.03.2023
Aromatic brominated flame retardants, such as polybrominated diphenyl ethers, are generally persistent in the environment. Many, like...
Direttiva 76/769/CEE del Consiglio, del 27 luglio 1976, concernente il ravvicinamento delle disposizioni legislative, regolamentari ed amministrative degli Stati Membri relative al...
Regolamento (UE) 2019/1691 della Commissione del 9 ottobre 2019 recante modifica dell’allegato V del regolamento (CE) n. 1907/2006 del Parlamento europeo e del Consiglio con...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
